(Q73320609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

I N Krasnova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E R Bychkov

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V I Lioudyno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

O E Zubareva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

number of pages

5

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

113-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

Is the mesocortical dopaminergic system involved in Parkinson disease?

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Adverse reactions to levodopa: drug toxicity or progression of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: possible relevance for the central processing of reward and aversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P-dopamine relationship in the rat substantia nigra: a light and electron microscopy study of double immunocytochemically labeled materials

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Modulation of the rat mesolimbic dopamine pathway by neurokinins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Striatal neuropeptide levels in Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Neuroprotective therapeutic strategies comparison of experimental and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

The role of neuropeptides in learning: focus on the neurokinin substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Trophic effect of various neuropeptides on the cultured ventral spinal cord of rat embryo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Neuroprotective therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P synaptic interactions with GABAergic and dopaminergic neurons in rat substantia nigra: an ultrastructural double-labeling immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P in the rat nucleus accumbens: ultrastructural localization in axon terminals and their relation to dopaminergic afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Effects of intranigral substance p and neurokinin a on striatal dopamine release—i. Interactions with substance p antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Striatal dopamine and glutamate release: effects of intranigral injections of substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P containing polymer implants protect against striatal excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem Parkinsonian brains

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Localization of striatal and nigral tachykinin receptors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Electrochemical studies of the effects of substance P on dopamine terminals in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900400-5

7 January 2021

10.1016/S0306-4522(99)00400-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10619467%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference